Lyra Therapeutics Inc. (LYRA) Social Stream
LYRA THERAPEUTICS INC (LYRA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering LYRA THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-10 | 3 | $25 | $24 | $24.5 | $5.26 | 365.78% |
| 2021-11-10 | 3 | $24 | $24 | $24 | $5.26 | 356.27% |
| 2022-03-09 | 3 | $24 | $15 | $19.5 | $5.26 | 270.72% |
| 2022-03-25 | 2 | $24 | $10 | $17 | $5.26 | 223.19% |
| 2022-05-11 | 4 | $24 | $14 | $19 | $5.26 | 261.22% |
| 2022-05-24 | 4 | $24 | $14 | $17.666 | $5.26 | 235.86% |
| 2023-01-27 | 4 | $18 | $14 | $15.666 | $5.26 | 197.83% |
| 2023-02-08 | 5 | $18 | $14 | $15.666 | $5.26 | 197.83% |
| 2023-05-15 | 5 | $20 | $14 | $16.75 | $5.26 | 218.44% |
| 2023-08-08 | 5 | $20 | $8 | $14.25 | $5.26 | 170.91% |
| 2023-08-09 | 5 | $20 | $8 | $14 | $5.26 | 166.16% |
| 2023-08-31 | 6 | $20 | $8 | $13.6 | $5.26 | 158.56% |
| 2023-09-12 | 6 | $20 | $8 | $14 | $5.26 | 166.16% |
| 2023-11-09 | 6 | $15 | $8 | $12.4 | $5.26 | 135.74% |
The Trend in the Analyst Price Target
Over the past 12 months, LYRA's average price target has gone down $2.67.
Over the past 41 weeks, LYRA's average upside potential has been 372.18%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-15 | 5 | 20 | 14 | 16.75 | 2.61 | 541.76% |
| 2023-08-09 | 5 | 20 | 8 | 14.00 | 3.29 | 325.53% |
| 2023-09-12 | 6 | 15 | 8 | 12.50 | 4.60 | 171.74% |
| 2023-10-06 | 6 | 15 | 8 | 13.00 | 3.64 | 257.14% |
| 2023-11-08 | 6 | 15 | 8 | 13.00 | 2.93 | 343.69% |
LYRA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
LYRA's average broker recommendation rating improved by 0 over the prior 153 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, LYRA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1993.56% of them.
- In the context of all US stocks, LYRA THERAPEUTICS INC's number of analysts covering the stock is greater than 414.51% of them.
- In terms of how LYRA THERAPEUTICS INC fares relative to all US stocks, note that its average analyst price target is greater than 442.36% of that group.
- In the context of Medical Equipment stocks, LYRA THERAPEUTICS INC's variance in analysts' estimates is lower than -1374.16% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to LYRA THERAPEUTICS INC are DCTH, PYPD, and LNSR.
View All Top Stocks by Price Target
Is LYRA a Buy, Hold or Sell? See the POWR Ratings now!